XML 62 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Jul. 31, 2022
Grant Date Fair Value Assumptions [Abstract]        
Share-based compensation $ 14,879,000 $ 15,187,000 $ 14,516,000  
Recognized tax benefits $ (10,800,000) $ (30,000,000) $ (28,600,000)  
Stock Options [Member]        
Stock option activity [Roll Forward]        
Beginning balance (in shares) 651,617      
Granted (in shares) 75,202      
Exercised (in shares) 71,737 274,253 482,361  
Forfeited (in shares) 12,157      
Ending balance (in shares) 642,925 651,617    
Exercisable (In Shares) 391,430      
Stock option weighted average exercise price [Abstract]        
Beginning balance (in dollars per share) $ 123.98      
Granted (in dollars per share) 371.80      
Exercised (in dollars per share) 87.09      
Forfeited (in dollars per share) 260.53      
Ending balance (in dollars per share) 154.57 $ 123.98    
Exercisable at end of period (in dollars per share) $ 87.02      
Weighted Average Remaining Contractual Term [Abstract]        
Weighted average remaining contractual term of shares outstanding (in years) 4 years 7 months 28 days      
Weighted average remaining contractual term of shares exercisable at end of period (in years) 2 years 10 months 2 days      
Aggregate Intrinsic Value [Abstract]        
Ending balance $ 101,227,921      
Exercisable at end of period $ 84,298,268      
Cash Proceeds and Tax Benefits [Abstract]        
Exercised (in shares) 71,737 274,253 482,361  
Cash proceeds $ 6,247,000 $ 14,435,000 $ 17,657,000  
Intrinsic value of options exercised 21,976,000 118,305,000 116,794,000  
Tax benefits realized $ 5,494,000 $ 29,576,000 $ 29,199,000  
Grant Date Fair Value Assumptions [Abstract]        
Expected volatility (in hundredths) 28.90% 27.00% 20.70%  
Expected term (in years) 7 years 1 month 6 days 6 years 10 months 24 days 6 years 9 months 18 days  
Risk-free interest rate (in hundredths) 2.92% 1.00% 1.22%  
Expected dividend yield (in hundredths) 1.15% 1.15% 1.30%  
Grant date fair value (in dollars per share) $ 116.56 $ 83.05 $ 42.52  
Share-based compensation $ 3,413,000 $ 2,846,000 $ 2,842,000  
Recognized tax benefits 853,000 712,000 710,000  
Unamortized compensation expense $ 8,700,000      
Expense recognition over weighted average period (in years) 3 years 3 months 18 days      
Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award performance period 3 years      
Shares available for grant 902,962      
Grant Date Fair Value Assumptions [Abstract]        
Share-based compensation $ 11,024,000 $ 11,543,000 $ 10,965,000  
Unamortized compensation expense $ 21,900,000      
Expense recognition over weighted average period (in years) 2 years 9 months 18 days      
Restricted stock awards [Roll Forward]        
Beginning balance (in shares) 260,738      
Granted (at market price) (in shares) 53,926      
Vested (in shares) 78,931 69,069 77,294  
Forfeited (in shares) 23,016      
Ending balance (in shares) 212,717 260,738    
Restricted stock awards weighted average grant date fair value [Abstract]        
Beginning balance (in dollars per share) $ 190.26      
Granted (at market price) (in dollars per share) 393.64      
Vested (in dollars per share) 137.60      
Forfeited (in dollars per share) 273.55      
Ending balance (in dollars per share) $ 256.97 $ 190.26    
Vested (in shares) 78,931 69,069 77,294  
Fair value of restricted stock awards vested $ 37,258,000 $ 24,005,000 $ 16,813,000  
ESPP Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares purchased under the ESPP (in shares) 7,658 8,649 10,929  
Grant Date Fair Value of most recent ESPP Purchase (per share)       $ 53.65
Grant Date Fair Value Assumptions [Abstract]        
Share-based compensation $ 500,000 $ 800,000 $ 700,000  
LTIP 2007 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares allocated for issuance (in shares) 9,315,000      
Shares available for grant 4,015,569      
Employee Stock Purchase Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares allocated for issuance (in shares) 956,250      
Discounted percentage rate offered under the employee stock purchase plan (in hundredths) 85.00%      
Minimum [Member] | Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award performance period, extension period 1 year      
Maximum [Member] | Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award performance period, extension period 2 years